US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalR
RPRX
Royalty Pharma Plc
31.13
-0.24-0.77%After Hours: 31.28 +0.15 +0.48%18:37 03/31 EDT
OPEN/PREV CLOSE30.89/31.37
TODAY RANGE30.64-31.31
VOL7.63M
MARKET CAP17.94B
52 WEEK RANGE23.89-34.20
AVG VOL (3M)4.51M
% TURNOVER1.32%
TURNOVER--
P/E (TTM)16.28
% RANGE2.14%
EPS(TTM)1.912
P/E(FORWARD)15.19
P/B2.640
BVPS11.79
DIVIDEND0.8800
P/S8.10
BETA--
DIV YIELD2.83%
FREE FLOAT MKT CAP12.04B
SHARES OUTSTANDING576.45M
NEXT EARNINGS05/07-05/12
FREE FLOAT386.88M
LOT SIZE1
EX-DIV DATE02/21/2025
News
Press Releases
Financial Reports
Profile
TipRanks·3d ago
Royalty Pharma pullback a buying opportunity, says Citi
Reuters·4d ago
ROYALTY PHARMA ANNOUNCES UPCOMING INVESTOR DAY
TipRanks·4d ago
TD Cowen Reaffirms Their Buy Rating on Royalty Pharma (RPRX)
Benzinga·03/19 17:15
How Do Investors Really Feel About Royalty Pharma?
Simply Wall St·03/19 13:53
Royalty Pharma plc's (NASDAQ:RPRX) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Seeking Alpha·03/10 18:55
Theravance Biopharma: Clinical Progress Is Not Enough To Make It Attractive
Seeking Alpha·02/26 17:12
Geron: Rytelo's Market Share Concerns Justified As 3L Dominates Early Sales
Benzinga·02/24 15:00
Peering Into Royalty Pharma's Recent Short Interest
Seeking Alpha·02/15 05:44
Dividend Champion, Contender, And Challenger Highlights: Week Of February 16
Seeking Alpha·02/13 16:03
17 Upcoming Dividend Increases, Including 3 Kings
Seeking Alpha·02/13 03:02
Royalty Pharma: Delivering Growth With A Positive Story Ahead
Same Industry
Name/Symbol
Change%
Price